Navigation Links
Gardasil Refused Subsidy

Cervical cancer vaccine, a world-first vaccine which has been shown to prevent 70 per cent of cervical cancers has been removed //from the national immunisation program, according to reports from Labor today.

The government's pharmaceutical advisory body has rejected an application today from Australian manufacturer CSL to make the vaccine Gardasil freely available to all females between ages 12 and 26.

Gardasil, the vaccine designed in Australia halts the spread of sexually-transmitted human papilloma virus (HPV), which causes 70 per cent of cervical cancer.

The NSW Cancer Council has estimated that around 700 Australian women are diagnosed with cervical cancer each year causing about 270 deaths.

Although the vaccine has been on the market for two months it costs $460 for patients to take the recommended three doses.

Only last week the Pharmaceutical Benefits Advisory Committee (PBAC) considered a subsidy for the drug at its regular meeting in Canberra.

CSL and Professor Ian Frazer, who was named Australian of the Year 2006 for designing the vaccine, have been informed today it had been knocked back due to its high price.


NLA
'"/>




Page: 1

Related medicine news :

1. Gardasil vaccine for cervical cancer
2. Gardasil- Cervical Cancer Vaccine Now Approved
3. Gardasil, a cervical cancer vaccine, hits the market
4. Gardasil Hailed as one of the Biggest Research Successes
5. Cervical Cancer Vaccine Gardasil Included In Subsidized CDC program
6. School Vaccination Program to Include Cancer Drug Gardasil
7. Developing Nations to Get Gardasil at Lesser Rates from Merck Soon
8. Gardasil – Cervical Cancer Vaccine in UA
9. Acid Test - Glaxos Cervarix, and Mercks Gardasil, Compete
10. Smoker Refused Treatment
11. Boy Refused Compensation For HIV Infection Following Hospital Admission
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: